Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
06/03/20248:03AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ELEstee Lauder Companies Inc
06/03/20248:02AMGlobeNewswire Inc.Ready Capital to Present at Nareit’s REITweek 2024NYSE:RCReady Capital Corporation 65
06/03/20248:02AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:CHTChunghwa Telecom Co Ltd
06/03/20248:02AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:LPTVLoop Media Inc
06/03/20248:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ILPTIndustrial Logistics Properties Trust
06/03/20248:02AMGlobeNewswire Inc.Rhythm Pharmaceuticals Announces Participation at Upcoming Investor ConferenceNASDAQ:RYTMRhythm Pharmaceuticals Inc
06/03/20248:02AMPR Newswire (US)MIT Sloan Management Review Research Examines Circular Business Models' Benefit to Bottom Line and Increased Sustainability Measures
06/03/20248:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
06/03/20248:01AMGlobeNewswire Inc.Texas Must Close Primary Elections
06/03/20248:01AMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:RFACWRF Acquisition Corporation
06/03/20248:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IOVAIovance Biotherapeutics Inc
06/03/20248:01AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FUTUFutu Holdings Ltd
06/03/20248:01AMGlobeNewswire Inc.Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024NASDAQ:MYNZMainz BioMed NV
06/03/20248:01AMPR Newswire (US)Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment StudiesNASDAQ:AEMDAethlon Medical Inc
06/03/20248:01AMPR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - OPTI
06/03/20248:00AMGlobeNewswire Inc.Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following Treatment with Bizaxofusp When Compared to a Matched External Control Arm at the 2024 ASCO Annual MeetingTSX:MDNAMedicenna Therapeutics Corp
06/03/20248:00AMGlobeNewswire Inc.Genesis Offers New Tools and Incentives to Financial Industry Software Developers
06/03/20248:00AMGlobeNewswire Inc.Denali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome Type A) for START Pilot Program Intended to Accelerate Development of Rare Disease TherapiesNASDAQ:DNLIDenali Therapeutics Inc
06/03/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:ZNOGWZion Oil and Gas Inc (PK)
06/03/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RFACWRF Acquisition Corporation
06/03/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:IRTIndependence Realty Trust Inc
06/03/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FYBRFrontier Communications Parent Inc
06/03/20248:00AMGlobeNewswire Inc.BriaCell Presents Clinical Efficacy Data at ASCO 2024NASDAQ:BCTXWBriaCell Therapeutics Corporation
06/03/20248:00AMGlobeNewswire Inc.BriaCell Presents Clinical Efficacy Data at ASCO 2024NASDAQ:BCTXBriaCell Therapeutics Corporation
06/03/20248:00AMGlobeNewswire Inc.BriaCell Presents Clinical Efficacy Data at ASCO 2024TSX:BCTBriaCell Therapeutics Corp
06/03/20248:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:VLNValens Semiconductor Ltd
06/03/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
06/03/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:KULRKULR Technology Group Inc
06/03/20248:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:BURBurford Capital Limited
06/03/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IPWiPower Inc